Journal of Infectious Diseases & Preventive Medicine
Open Access

Vaccinating for Prevention: Protecting Individuals and Communities from Infectious Diseases

Hunold Jordi^{* *}Correspondence: Hunold Jordi, Department of Biosciences, University of Milan, Milano, Italy, Email:

Author info »

Description

Vaccination is one of the most effective and transformative public health tools ever developed. It is responsible for saving millions of lives each year, preventing debilitating illnesses, and protecting entire communities from the spread of infectious diseases. The principle of vaccines plays in protecting both individuals and communities from infectious diseases and highlight why widespread immunization is essential for maintaining public health [1].

Vaccination

Vaccination works by stimulating the body’s immune system to recognize and fight off pathogens, such as viruses and bacteria, without causing the disease itself [2]. Vaccines contain components of these pathogens either inactivated viruses, bacteria, or pieces of their genetic material that teach the immune system to identify and respond to the pathogen if it is encountered in the future. By introducing a small, harmless fragment of the pathogen into the body, the immune system produces antibodies and creates immune memory [3-5]. This preventive approach can help people avoid suffering from illnesses that can cause long-term complications, disability, or death. Some diseases, such as measles, diphtheria, and whooping cough, can be especially severe in infants, young children, and the elderly [6]. Vaccination is especially critical for these vulnerable populations, as they are more likely to suffer severe complications or even die from infectious diseases [7].

Vaccines not only protect individuals directly but also reduce the risk of these diseases spreading. For instance, the HPV vaccine (Human Papillomavirus) helps prevent certain cancers, including cervical cancer, by preventing infection with HPV, a virus that is the leading cause of these cancers [8]. Hepatitis B vaccination prevents liver cancer, and influenza vaccines can prevent severe illness, particularly in those at high risk, such as the elderly, pregnant women, and individuals with chronic health conditions [9].

Herd immunity

While individual protection is a central goal of vaccination, there is another essential benefit: Community protection, also known as herd immunity. When enough people are immune to a particular pathogen, its spread is significantly reduced because there are fewer individuals for the pathogen to infect [10].

Herd immunity is particularly important for those who cannot receive vaccines such as individuals with compromised immune systems, the elderly, or infants who are too young to be vaccinated. This means that even if some individuals cannot be vaccinated, they are still protected because the overall level of immunity in the population prevents the disease from circulating. For herd immunity to be effective, a high percentage of the population must be vaccinated. For highly contagious diseases like measles, about 95% of the population must be vaccinated to prevent outbreaks [11].

Vaccination has had a profound impact on global health, leading to the eradication or near-eradication of some of the deadliest diseases known to humanity. One of the greatest successes in public health history has been the eradication of smallpox, which was achieved through a global vaccination campaign. Measles, once a leading cause of childhood death, has also seen dramatic reductions in mortality rates due to widespread vaccination. Despite these successes, outbreaks continue to occur in some parts of the world due to gaps in vaccination coverage, particularly in areas where vaccine misinformation, political instability, or poor healthcare access undermine immunization efforts [12].

Conclusion

Vaccination is a core of public health, protecting individuals from life-threatening diseases while also safeguarding entire communities. Through herd immunity and the widespread availability of vaccines, we have been able to reduce the prevalence of infectious diseases and even eradicate some entirely. However, the global community must continue to invest in vaccination programs, address vaccine hesitancy, and ensure that vaccines remain accessible to everyone, regardless of their location or socio-economic status.

References

1. Anderson EJ, Daugherty MA, Pickering LK, Orenstein WA, Yogev R. Protecting the community through child vaccination. Clin Infect Dis. 2018;67(3):464-471.

   [Crossref] [Google Scholar] [PubMed]

2. Dushoff J, Plotkin JB, Viboud C, Simonsen L, Miller M, Loeb M, Earn DJ. Vaccinating to protect a vulnerable subpopulation. PLoS Med. 2007;4(5):e174.

   [Crossref] [Google Scholar] [PubMed]

3. Anderson RM, May RM. Directly transmitted infections diseases: Control by vaccination. Science. 1982;215(4536):1053-1060.

   [Crossref] [Google Scholar] [PubMed]

4. Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vaccines Immunother. 2015;11(11):2627-2636.

   [Crossref] [Google Scholar] [PubMed]

5. Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793-802.

   [Crossref] [Google Scholar] [PubMed]

6. Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257-2264.

   [Crossref] [Google Scholar] [PubMed]

7. Dhama K, Sharun K, Tiwari R, Dhawan M, Emran TB, Rabaan AA, et al. COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccines Immunother. 2021;17(10):3495-3499.

   [Crossref] [Google Scholar] [PubMed]

8. Mercer A. Protection against severe infectious disease in the past. Pathog Glob Health. 2021;115(3):151-167.

   [Crossref] [Google Scholar] [PubMed]

9. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58(4):470-480.

   [Crossref] [Google Scholar] [PubMed]

10. Amin AN, Parra MT, Kim-Farley R, Fielding JE. Ethical issues concerning vaccination requirements. Public Health Rev. 2012;34:1-20.

    [Crossref] [Google Scholar]

11. Plotkin S, Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis. 2008;47(10):1328-1338.

    [Crossref] [Google Scholar] [PubMed]

12. Rodgers GL, Whitney CG, Klugman KP. Triumph of pneumococcal conjugate vaccines: overcoming a common foe. J Infect Dis. 2021;224(Supplement_4): S352-S359.

    [Crossref] [Google Scholar] [PubMed]